If you want to help us develop transformative technology that meets an unaddressed medical need, contact us today.
3i Diagnostics has entered an $11.5 billion market with a compound annual growth rate (CAGR) of 12%. We intend to create an additional new market of over $10 billion.
Our current go-to-market strategy is to focus on helping healthcare providers deal with the staggering challenge of treating blood infections. We will then build assays for other samples such as swabs and sputum.
We plan to first release a research-use-only version of our new technology platform to help researchers discover new ways to fight resistant microbes and to allow rapid detection and identification of microbes in non-clinical applications.
If you’d like to join us in our mission, we’d like to hear from you.
3i DIAGNOSTICS, INC., 20271 GOLDENROD LANE V5, GERMANTOWN, MD 20876